In this series, ‘Genomics 101’, we go back to basics and explore some of the most important topics in genomics. In this blog, ...
A new statistical framework could speed up the search for rare mutations that cause common diseases, helping researchers zero ...
Shares of genetic testing company Myriad Genetics (NASDAQ:MYGN) jumped 9.2% in the morning session after the company expanded ...
Jacksonville Journal-Courier on MSN
A twist of genetics: How and why landscape plants revert
From time to time, plant mutations are not maintained, resulting in a phenomenon called reversion.
Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announces expanded availability of Precise ...
StockStory.org on MSN
Spotting winners: Myriad Genetics (NASDAQ:MYGN) and therapeutics stocks in Q1
Wrapping up Q1 earnings, we look at the numbers and key takeaways for the therapeutics stocks, including Myriad Genetics ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results